Eckental, Germany

Klaus Mayer

USPTO Granted Patents = 13 

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 124(Granted Patents)


Location History:

  • Regensburg, DE (1996)
  • Eckental, DE (2008 - 2011)
  • Munich, DE (1993 - 2024)

Company Filing History:


Years Active: 1993-2025

where 'Filed Patents' based on already Granted Patents

13 patents (USPTO):

Title: Klaus Mayer: Innovator in Antibody Technology

Introduction

Klaus Mayer is a distinguished inventor based in Eckental, Germany, known for his significant contributions to the field of antibody technology. With a total of 13 patents to his name, Mayer has made remarkable advancements in the generation of multispecific antibodies, which have important implications in therapeutic applications.

Latest Patents

Mayer's latest patents include innovative methods for generating multispecific antibodies from monospecific antibodies. One notable patent describes a method for generating multispecific antibodies through a half-antibody exchange reaction between two 2/3-IgGs. This method allows for the generation of correctly assembled full-length bispecific antibodies without the need for reducing agents or hinge region disulfide bonds in the starting materials. Another patent outlines a method for in vivo generation of multispecific antibodies directly on the cell surface at the site of action, utilizing a similar half-antibody exchange reaction. This approach also eliminates the requirement for hinge region disulfide bonds, enhancing the efficiency of antibody generation.

Career Highlights

Throughout his career, Klaus Mayer has worked with prominent companies such as Siemens Aktiengesellschaft and Hoffmann-La Roche Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and antibody development.

Collaborations

Mayer has collaborated with notable colleagues, including Ulrich Brinkmann and Cecile Mohr, further enriching his research and innovation in antibody technology.

Conclusion

Klaus Mayer's work in the field of antibody technology exemplifies the impact of innovative thinking in biotechnology. His patents and collaborations highlight his commitment to advancing medical science through the development of multispecific antibodies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…